NCT03909425View on ClinicalTrials.gov

Defining Disease Activity in Neovascular AMD With Optical Coherence Tomography Angiography

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

September 2, 2019

Primary Completion Date

August 16, 2021

Study Completion Date

August 16, 2021

Conditions
Neovascular Age-related Macular Degeneration
Trial Locations (1)

EC1V 2PD

Moorfields Eye Hospital NHS Foundation Trust, 162 City Road, London

All Listed Sponsors
lead

Moorfields Eye Hospital NHS Foundation Trust

OTHER

NCT03909425 - Defining Disease Activity in Neovascular AMD With Optical Coherence Tomography Angiography | Biotech Hunter | Biotech Hunter